INTRODUCTION
The presence of lymphocytotoxic antibody has been described in patients with systemic lupus erythematosus (SLE)' (1, 2) and also the New Zealand black (NZB) mouse (3) , an animal which often develops a disease closely resembling SLE. In both man (4) and the NZB mouse (3), lymphocytotoxic antibodies show relative specificity for thymus-derived or T lymphocytes; this phenomenon may be related to the alterations in T lymphocytes which accompany exacerbations of disease activity (5) . The discovery of "viral-like" inclusions in tissues of SLE patients (6, 7) has stimulated speculation that this disease may be caused by a virus (8) . Because lymphocytotoxic antibody has been described in several disease states of definite or probable viral origin (9) (10) (11) , the current study was initiated to determine if lymphocytotoxic antibodies might serve as a marker of Received for publication 13 December 1974 and in revised formt 23 January 1975. 'Abbreviations used in this paper: B lymphocyte, bone marrow-derived lymphocyte; CLL, chronic lymphocytic leukemia; HL-A, histocompatibility antigen; NZB, New Zealand black; SLE, systemic lupus erythematosus; T lymphocyte, thymus-derived lymphocyte.
exposure to an environmental agent in families of patients with SLE.
METHODS
A total of 26 families which contained 28 patients with SLE were studied. All patients met the preliminary diagnostic criteria for SLE published by the American Rheumatism Association (12) . One family contained a pair of identical twins, both of whom had active lupus nephritis. A second family contained two sisters, both of whom had active SLE. Sera from 124 family members were studied. First-degree relatives were defined as parents, children, and siblings of the proband while second-degree relatives were twice removed from the proband (i.e., grandparents, uncles, aunts, neices, and nephews). The family members were also divided into close household contacts and nonhousehold contacts. Close household contacts lived in the same house or had daily contact with the proband within the year before the onset and during the course of the proband's illness. Nonhousehold contacts included all relatives who did not live with the proband and had only casual contact with the proband during this time period. Sera were obtained from all of the household contacts and 21 of the 30 nonhousehold contacts within 4 wk of an acute exacerbation of the disease in the proband (13 (15) . Each serum was tested against lymphocytes from 15-60 normal individuals. The mean number of donors in the normal test panels was 30. The histocompatibility antigens (HL-A) of the donor lymphocytes were determined to assure that a wide spectrum of antigens were included in the panel. The microcytotoxicity method of Terasaki and McClelland (16) was used with 15'C incubations for 3 h after the addition of rabbit complement which was previously determined as optimal for the detection of lymphocytotoxins in patients with SLE (4). An individual test was considered positive if 20% or more of the lymphocytes from one donor were killed by a given serum. A strongly positive test had 80% or more of the donor lymphocytes killed by an individual serum. A serum was considered positive only if it killed 20% or more of the cells from at least half the donors in the panel. This criteria was chosen at the onset of the study before analysis of the data as one that would assure that we would be dealing with sera with broad cytotoxic activity. Negative sera, human serum albumin, and suitable controls for cell lysis alone consistently showed no more than 0-10% death of the target lymphocytes. All tests were read blind by an independent observer without knowledge of diagnosis or family status. Antinuclear antibodies were determined as previously described (17) and gamma globulin levels were estimated by cellulose acetate electrophoresis. Chi square analysis was used in all statistical comparisons between and within individual groups (18) . RESULTS When the entire group of SLE family members was examined, 57% of 124 sera showed broad lymphocytotoxic antibody activity while only 3% of the 60 control sera demonstrated this phenomenon (Table II) . No differences were noted between consanguineous and nonconsanguineous relatives of SLE patients. A considerably higher percentage of sera with lymphocytotoxic antibody activity (73%) was noted in the 74 consanguineous family members who had close household contact with the probands as compared to the 30 consanguineous relatives who did not have close household contact (Table III) . With the exception of the nonhousehold consanguineous relatives, a significantly higher percentage of strongly positive tests (greater than 80% killing) was found in SLE * Percent of donor lymphocyte panel killed by sera. $ Indicates a P < 0.0001 compared to controls. § Indicates a P < 0.025 when compared to controls.
11 Indicates a P < 0.0001 compared to consanguineous household contacts. family sera when compared to controls (P < 0.0001).
Lymphocytotoxic Antibodies in SLE Families
A total of 60% of the tests between SLE family sera and normal donor lymphocytes were positive compared to 13% of the tests with control family sera. Analysis of the 20 nonconsanguineous relatives of the probands revealed that 50% of these family members had lymphocytotoxic antibody. When the 1 female and 14 male spouses of the SLE probands were examined, 7 of 15 (47%) had lymphocytotoxic antibody. Moreover, in several situations where SLE probands lived with in-laws or with children from the spouse's previous marriage, substantial proportions (three of five) of these nonconsanguineous relatives showed lymphocytotoxic antibodies. When all consanguineous relatives were analyzed with respect to their relationship to the proband, 49 of the 68 (72%) first-degree relatives and 5 of 6 (83%) second-degree relatives with close household contact showed lymphocytotoxic antibody (Table  IV) . However, only 4 of 18 (22%) first-degree and 3 of 12 (25%) second-degree relatives without close household contact with the proband had lymphocytotoxins (Table IV) studied on three separate occasions over a 12-mo period with no significant change in lymphocytotoxic activity.
Specificity of the lymphocytotoxic antibody in SLE family sera was examined with different target cells. If lymphocytes from the proband SLE patients were used, 9% of control sera and 73% of family sera were positive. Again no difference was noted between consanguineous and nonconsanguineous relatives. Sera from a given family showed no selectivity for the proband in that family. In contrast, only 4% of SLE family sera and 3% of control family sera were positive when CLL lymphocytes (95% or greater B lymphocytes) were used as target cells. Lymphocytotoxic antibody in family members or patients did not appear to show specificity for lymphocytes of any particular HL-A type. The incidence of both antinuclear antibody and gamma globulin elevation was 3% in the families of our SLE patients.
DISCUSSION
The incidence of lymphocytotoxic antibody in a large group of relatives of patients with SLE was considerably higher than that found in control families. Lymphocytotoxic antibodies are rarely found in normal individuals (9) execpt after multiple pregnancies or transfusions (19) . Moreover, the distribution of lymphocytotoxins far exceeded that of other serologic markers such as antinuclear antibodies or gamma globulin elevations recorded during previous family studies of SLE probands (20, 21) .
As noted in Table I (Table III) , whereas only occasional control family sera showed such strong reactions. SLE family members showed 13 times as many strongly cytotoxic reactions as control family sera tested.
Like those in SLE patients, the antibodies in their relatives appear to react with T lymphocytes. However, some sera which kill 100% of normal lymphocytes must also contain antibodies directed against B lymphocytes or common B-and T-cell antigens. It is apparent from the reaction patterns of sera form both patients (4) and their relatives that antigens occurring on normal lymphocytes are involved. These lymphocytotoxic antibodies do not have specificity for cells from patients with SLE. The slightly higher percentage of positive reactions with SLE family and control sera noted when SLE lymphocytes were used as targets can probably be explained by autosensitization of the cells with antilymphocyte antibodies in vitro (22) . One explanation for this activity with normal cells is that new antigens appearing on SLE lymphocytes as the result of a virus infection (23) induce antibody against normal lymphocyte antigens as well as the new antigens (24) . The suggestion that certain viruses may preferentially infect T lymphocytes (25) strengthens the hypothesis (8, 26) that a virus infection through its effect on T cells may be involved in the pathogenesis of SLE.
\Vhen individual SLE families were examined no clear genetic pattern of the inheritance of lymphocytotoxic antibody was recognized. Furthermore, the data showing an equal incidence of lymphocytotoxic antibodies in both consanguineous and nonconsanguineous household contacts of SLE probands are strong evidence against a purely genetic distribution. The 47% positive incidence of lymphocytotoxic antibody among spouses of SLE probands is pertinent in this regard. When these facts are considered together, the distribution of lymphocytotoxic antibodies in SLE families could be interpreted as evidence for a common environmental or infectious exposure.
Both environmental and genetic factors may be important in the production of disease in animal models of SLE. This is exemplified in both the dog and the NZB mouse models, where recent evidence suggests that both horizontal and vertical transmission of markers of the disease may occur (27, 28) . In man, a clear genetic predisposition has not been found in twin studies (29, 30) nor has a definite relationship between HL-A markers and SLE been defined (31 
